93 related articles for article (PubMed ID: 23016269)
21. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
[TBL] [Abstract][Full Text] [Related]
22. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
[TBL] [Abstract][Full Text] [Related]
23. The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.
Guo SS; Tang LQ; Zhang L; Chen QY; Liu LT; Guo L; Mo HY; Luo DH; Huang PY; Xiang YQ; Sun R; Chen MY; Wang L; Lv X; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
BMC Cancer; 2015 Dec; 15():977. PubMed ID: 26675209
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and outcome for nasopharyngeal carcinoma.
Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
26. Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma.
Guo R; Mao YP; Chen L; Tang LL; Zhou GQ; Liu LZ; Tian L; Zeng MS; Jia WH; Shao JY; Lin AH; Ma J
Oncotarget; 2017 Feb; 8(6):10594-10601. PubMed ID: 27070084
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma.
Liu LT; Tang LQ; Chen QY; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):862-9. PubMed ID: 26530755
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
Loong HH; Ma BB; Leung SF; Mo F; Hui EP; Kam MK; Chan SL; Yu BK; Chan AT
Radiother Oncol; 2012 Sep; 104(3):300-4. PubMed ID: 22300609
[TBL] [Abstract][Full Text] [Related]
31. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
32. High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy.
Fu X; Hu J; Han HY; Hua YJ; Zhou L; Shuai WD; Du WY; Kuang CM; Chen S; Huang W; Liu RY
Oncotarget; 2015 Sep; 6(29):28478-90. PubMed ID: 26156020
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008.
Chee Ee Phua V; Loo WH; Yusof MM; Wan Ishak WZ; Tho LM; Ung NM
Asian Pac J Cancer Prev; 2013; 14(8):4567-70. PubMed ID: 24083703
[TBL] [Abstract][Full Text] [Related]
34. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
35. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Penang General Hospital from 2001-2005.
Phua CE; Tan BS; Yong TK; Govindasamy M
Asian Pac J Cancer Prev; 2011; 12(12):3197-200. PubMed ID: 22471453
[TBL] [Abstract][Full Text] [Related]
39. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
[TBL] [Abstract][Full Text] [Related]
40. Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Zhang LN; Gao YH; Lan XW; Tang J; Su Z; Ma J; Deng W; OuYang PY; Xie FY
Oncotarget; 2015 Dec; 6(41):44019-29. PubMed ID: 26528755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
